Back to calendar
Halozyme Therapeutics, Inc. (HALO) Earnings
HALO reports earnings on Monday, November 9, 2026
earnings report
November 9, 2026 · Before Market Open
Q3 2026
Est. EPS: $2.30
Actual EPS: $2.28
EPS surprise: 27.58%
Company overview
Market Cap$13.8B
PriceUSD 121.84
P/E36.40
EPS (TTM)3.35
52-week high122.44
52-week low61.23
SectorHealth Technology
IndustryBiotechnology
Employees423